{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T07:04:33Z","timestamp":1793430273116,"version":"4.5.0"},"reference-count":42,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Toxicology and Applied Pharmacology"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/j.taap.2025.117629","type":"journal-article","created":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T16:54:41Z","timestamp":1762534481000},"page":"117629","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["CDKN3 promoted triple-negative breast cancer by inhibiting ferroptosis through the upregulation of HSP90"],"prefix":"10.1016","volume":"506","author":[{"given":"Qiqi","family":"Zhao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yufang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"8","key":"10.1016\/j.taap.2025.117629_bb0005","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1200\/JCO.19.01203","article-title":"Dietary supplement use during chemotherapy and survival outcomes of patients with breast cancer enrolled in a cooperative group clinical trial (SWOG S0221)","volume":"38","author":"Ambrosone","year":"2020","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.taap.2025.117629_bb0010","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2020.106535","article-title":"Breast cancer: biology, biomarkers, and treatments","volume":"84","author":"Barzaman","year":"2020","journal-title":"Int. Immunopharmacol."},{"issue":"1","key":"10.1016\/j.taap.2025.117629_bb0015","doi-asserted-by":"crossref","DOI":"10.3390\/cancers12010164","article-title":"Ferroptosis in cancer cell biology","volume":"12","author":"Bebber","year":"2020","journal-title":"Cancers"},{"issue":"10","key":"10.1016\/j.taap.2025.117629_bb0020","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1517\/14728222.2014.941808","article-title":"Targeting CDKN3 in cervical cancer","volume":"18","author":"Berumen","year":"2014","journal-title":"Expert Opin. Ther. Targets"},{"issue":"5","key":"10.1016\/j.taap.2025.117629_bb0025","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.tcb.2021.01.010","article-title":"New insights into CDK regulators: novel opportunities for cancer therapy","volume":"31","author":"Bury","year":"2021","journal-title":"Trends Cell Biol."},{"issue":"6","key":"10.1016\/j.taap.2025.117629_bb0030","doi-asserted-by":"crossref","DOI":"10.1016\/j.labinv.2023.100122","article-title":"GID2 interacts with CDKN3 and regulates pancreatic cancer growth and apoptosis","volume":"103","author":"Deng","year":"2023","journal-title":"Lab. Investig. J. Tech. Methods Pathol."},{"issue":"8","key":"10.1016\/j.taap.2025.117629_bb0035","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1016\/j.cmet.2021.05.016","article-title":"Peroxidation of n-3 and n-6 polyunsaturated fatty acids in the acidic tumor environment leads to ferroptosis-mediated anticancer effects","volume":"33","author":"Dierge","year":"2021","journal-title":"Cell Metab."},{"issue":"110","key":"10.1016\/j.taap.2025.117629_bb0040","first-page":"215","article-title":"Heat shock proteins and their characteristics","volume":"19","author":"Dzaman-Serafin","year":"2005","journal-title":"Pol. Merkur. Lekarski"},{"key":"10.1016\/j.taap.2025.117629_bb0045","doi-asserted-by":"crossref","first-page":"5817","DOI":"10.2147\/IJGM.S438479","article-title":"Comprehensive analysis reveals the potential roles of CDKN3 in pancancer and verification in endometrial cancer","volume":"16","author":"Gao","year":"2023","journal-title":"Int. J. Gen. Med."},{"key":"10.1016\/j.taap.2025.117629_bb0050","doi-asserted-by":"crossref","DOI":"10.1016\/j.jep.2023.117655","article-title":"Danggui Buxue Tang improves therapeutic efficacy of doxorubicin in triple negative breast cancer via ferroptosis","volume":"323","author":"Gong","year":"2024","journal-title":"J. Ethnopharmacol."},{"issue":"4","key":"10.1016\/j.taap.2025.117629_bb0055","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1038\/s41580-020-00324-8","article-title":"Ferroptosis: mechanisms, biology and role in disease","volume":"22","author":"Jiang","year":"2021","journal-title":"Nat. Rev. Mol. Cell Biol."},{"issue":"9","key":"10.1016\/j.taap.2025.117629_bb0060","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2022.110448","article-title":"CDK\/cyclin dependencies define extreme cancer cell-cycle heterogeneity and collateral vulnerabilities","volume":"38","author":"Knudsen","year":"2022","journal-title":"Cell Rep."},{"issue":"2","key":"10.1016\/j.taap.2025.117629_bb0065","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1002\/JLB.3MA1220-815RRR","article-title":"IFN\u03b3-mediated repression of system xc(\u2212) drives vulnerability to induced ferroptosis in hepatocellular carcinoma cells","volume":"110","author":"Kong","year":"2021","journal-title":"J. Leukoc. Biol."},{"issue":"4","key":"10.1016\/j.taap.2025.117629_bb0070","doi-asserted-by":"crossref","first-page":"1825","DOI":"10.3892\/or.2014.3045","article-title":"CDKN3 is an independent prognostic factor and promotes ovarian carcinoma cell proliferation in ovarian cancer","volume":"31","author":"Li","year":"2014","journal-title":"Oncol. Rep."},{"issue":"7","key":"10.1016\/j.taap.2025.117629_bb0075","first-page":"3614","article-title":"CDKN3 regulates cisplatin resistance to colorectal cancer through TIPE1","volume":"24","author":"Li","year":"2020","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"key":"10.1016\/j.taap.2025.117629_bb0080","doi-asserted-by":"crossref","first-page":"299","DOI":"10.2147\/OTT.S358008","article-title":"CDKN3 overcomes bladder cancer cisplatin resistance via LDHA-dependent glycolysis reprogramming","volume":"15","author":"Li","year":"2022","journal-title":"Onco. Targets. Ther."},{"issue":"9","key":"10.1016\/j.taap.2025.117629_bb0085","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1038\/s41419-022-05242-5","article-title":"Inhibition of cannabinoid receptor type 1 sensitizes triple-negative breast cancer cells to ferroptosis via regulating fatty acid metabolism","volume":"13","author":"Li","year":"2022","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.taap.2025.117629_bb0090","doi-asserted-by":"crossref","DOI":"10.1016\/j.ecoenv.2022.113523","article-title":"Transcriptomics analysis and benchmark concentration estimating-based in vitro test with IOSE80 cells to unveil the mode of action for female reproductive toxicity of bisphenol a at human-relevant levels","volume":"237","author":"Li","year":"2022","journal-title":"Ecotoxicol. Environ. Saf."},{"issue":"9","key":"10.1016\/j.taap.2025.117629_bb0095","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1016\/j.molmed.2023.05.013","article-title":"FSP1: a key regulator of ferroptosis","volume":"29","author":"Li","year":"2023","journal-title":"Trends Mol. Med."},{"issue":"2","key":"10.1016\/j.taap.2025.117629_bb0100","doi-asserted-by":"crossref","first-page":"295","DOI":"10.3724\/abbs.2024138","article-title":"Hsp90\u03b1 promotes chemoresistance in pancreatic cancer by regulating Keap1-Nrf2 axis and inhibiting ferroptosis","volume":"57","author":"Liu","year":"2024","journal-title":"Acta Biochim. Biophys. Sin. Shanghai"},{"issue":"8","key":"10.1016\/j.taap.2025.117629_bb0105","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1038\/s41417-023-00609-y","article-title":"PSMD12 interacts with CDKN3 and facilitates pancreatic cancer progression","volume":"30","author":"Ma","year":"2023","journal-title":"Cancer Gene Ther."},{"issue":"1","key":"10.1016\/j.taap.2025.117629_bb0110","doi-asserted-by":"crossref","DOI":"10.1002\/iub.2922","article-title":"CDKN3 as a key regulator of G2M phase in triple-negative breast cancer: insights from multi-transcriptomic analysis","volume":"77","author":"Ma","year":"2025","journal-title":"IUBMB Life"},{"issue":"6","key":"10.1016\/j.taap.2025.117629_bb0115","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1016\/j.ccell.2023.05.001","article-title":"CDKN2A deletion remodels lipid metabolism to prime glioblastoma for ferroptosis","volume":"41","author":"Minami","year":"2023","journal-title":"Cancer Cell"},{"issue":"2","key":"10.1016\/j.taap.2025.117629_bb0120","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1111\/cas.13458","article-title":"PRDM14 directly interacts with heat shock proteins HSP90\u03b1 and glucose-regulated protein 78","volume":"109","author":"Moriya","year":"2018","journal-title":"Cancer Sci."},{"issue":"16","key":"10.1016\/j.taap.2025.117629_bb0125","doi-asserted-by":"crossref","first-page":"3149","DOI":"10.7150\/ijbs.46645","article-title":"Identification of a novel cancer stem cell subpopulation that promotes progression of human fatal renal cell carcinoma by single-cell RNA-seq analysis","volume":"16","author":"Pan","year":"2020","journal-title":"Int. J. Biol. Sci."},{"issue":"11","key":"10.1016\/j.taap.2025.117629_bb0130","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1038\/s41419-022-05373-9","article-title":"HSP90 mediates the connection of multiple programmed cell death in diseases","volume":"13","author":"Peng","year":"2022","journal-title":"Cell Death Dis."},{"issue":"26","key":"10.1016\/j.taap.2025.117629_bb0135","doi-asserted-by":"crossref","first-page":"6618","DOI":"10.7150\/jca.33433","article-title":"Significant prognostic values of differentially expressed-aberrantly methylated hub genes in breast cancer","volume":"10","author":"Qi","year":"2019","journal-title":"J. Cancer"},{"issue":"5","key":"10.1016\/j.taap.2025.117629_bb0140","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1038\/s10038-020-00865-y","article-title":"Molecular pathogenesis of breast cancer: impact of miR-99a-5p and miR-99a-3p regulation on oncogenic genes","volume":"66","author":"Shinden","year":"2021","journal-title":"J. Hum. Genet."},{"key":"10.1016\/j.taap.2025.117629_bb0145","article-title":"Localized disruption of redox homeostasis boosting ferroptosis of tumor by hydrogel delivery system","volume":"12","author":"Su","year":"2021","journal-title":"Mater. Today. Bio"},{"issue":"9","key":"10.1016\/j.taap.2025.117629_bb0150","doi-asserted-by":"crossref","first-page":"2058","DOI":"10.1002\/1878-0261.12686","article-title":"Novel C-terminal heat shock protein 90 inhibitors target breast cancer stem cells and block migration, self-renewal, and epithelial-mesenchymal transition","volume":"14","author":"Subramanian","year":"2020","journal-title":"Mol. Oncol."},{"issue":"3","key":"10.1016\/j.taap.2025.117629_bb0155","first-page":"209","article-title":"Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J. Clin."},{"issue":"9","key":"10.1016\/j.taap.2025.117629_bb0160","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1507\/endocrj.EJ18-0536","article-title":"Regulation of growth hormone biosynthesis by Cdk5 regulatory subunit associated protein 1-like 1 (CDKAL1) in pituitary adenomas","volume":"66","author":"Takesue","year":"2019","journal-title":"Endocr. J."},{"key":"10.1016\/j.taap.2025.117629_bb0165","doi-asserted-by":"crossref","first-page":"3253","DOI":"10.2147\/CMAR.S193793","article-title":"CDKN3 promotes tumor progression and confers cisplatin resistance via RAD51 in esophageal cancer","volume":"11","author":"Wang","year":"2019","journal-title":"Cancer Manag. Res."},{"issue":"1","key":"10.1016\/j.taap.2025.117629_bb0170","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1186\/s13019-021-01534-7","article-title":"Integrated transcriptomics explored the cancer-promoting genes CDKN3 in esophageal squamous cell cancer","volume":"16","author":"Wang","year":"2021","journal-title":"J. Cardiothorac. Surg."},{"issue":"8","key":"10.1016\/j.taap.2025.117629_bb0175","doi-asserted-by":"crossref","first-page":"2996","DOI":"10.1073\/pnas.1819728116","article-title":"Chaperone-mediated autophagy is involved in the execution of ferroptosis","volume":"116","author":"Wu","year":"2019","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.taap.2025.117629_bb0180","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2022.1017041","article-title":"Ferroptosis and triple-negative breast cancer: potential therapeutic targets","volume":"12","author":"Xu","year":"2022","journal-title":"Front. Oncol."},{"issue":"1","key":"10.1016\/j.taap.2025.117629_bb0185","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.cmet.2022.09.021","article-title":"Ferroptosis heterogeneity in triple-negative breast cancer reveals an innovative immunotherapy combination strategy","volume":"35","author":"Yang","year":"2023","journal-title":"Cell Metab."},{"issue":"1","key":"10.1016\/j.taap.2025.117629_bb0190","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1186\/s12951-021-01058-1","article-title":"Simvastatin induced ferroptosis for triple-negative breast cancer therapy","volume":"19","author":"Yao","year":"2021","journal-title":"J Nanobiotechnol."},{"issue":"1","key":"10.1016\/j.taap.2025.117629_bb0195","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1186\/s13058-020-01296-5","article-title":"Triple-negative breast cancer molecular subtyping and treatment progress","volume":"22","author":"Yin","year":"2020","journal-title":"Breast Cancer Res."},{"issue":"1","key":"10.1016\/j.taap.2025.117629_bb0200","first-page":"542","article-title":"CDKN3 promotes cell proliferation, invasion and migration by activating the AKT signaling pathway in esophageal squamous cell carcinoma","volume":"19","author":"Yu","year":"2020","journal-title":"Oncol. Lett."},{"issue":"5","key":"10.1016\/j.taap.2025.117629_bb0205","first-page":"4535","article-title":"CDKN3 knockdown reduces cell proliferation, invasion and promotes apoptosis in human ovarian cancer","volume":"8","author":"Zhang","year":"2015","journal-title":"Int. J. Clin. Exp. Pathol."},{"issue":"7","key":"10.1016\/j.taap.2025.117629_bb0210","doi-asserted-by":"crossref","first-page":"3167","DOI":"10.7150\/thno.52028","article-title":"Holo-lactoferrin: the link between ferroptosis and radiotherapy in triple-negative breast cancer","volume":"11","author":"Zhang","year":"2021","journal-title":"Theranostics"}],"container-title":["Toxicology and Applied Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041008X25004053?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041008X25004053?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,8]],"date-time":"2026-06-08T08:53:17Z","timestamp":1780908797000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0041008X25004053"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":42,"alternative-id":["S0041008X25004053"],"URL":"https:\/\/doi.org\/10.1016\/j.taap.2025.117629","relation":{},"ISSN":["0041-008X"],"issn-type":[{"value":"0041-008X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"CDKN3 promoted triple-negative breast cancer by inhibiting ferroptosis through the upregulation of HSP90","name":"articletitle","label":"Article Title"},{"value":"Toxicology and Applied Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.taap.2025.117629","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"117629"}}